Published: August 31, 2026 · Last updated: September 1, 2026
Zombie-cell signaling, explained
Scientific review: This article is reviewed with doctoral-level scientific oversight.
Evidence standard: Human, animal, and laboratory findings are distinguished throughout.
Read our Editorial & Research Standards →
Senescent cells do more than simply stop dividing. Many remain biologically active and release signaling molecules into their surroundings. Researchers call this collection of signals the senescence-associated secretory phenotype, or SASP.
What exactly is SASP?
SASP is not one substance. It is a changing mixture of molecules released by certain senescent cells. Depending on the cell and biological setting, it can include inflammatory cytokines, chemokines, growth factors, proteases and other signaling molecules.
These signals allow a senescent cell to communicate with nearby cells, immune cells and the surrounding tissue environment.
This is one reason researchers are interested in “zombie cells”: even though they no longer divide, some can continue influencing what happens around them.
Does every senescent cell produce the same SASP?
No. There is no single universal SASP.
Its composition can vary depending on the type of cell, what caused the cell to become senescent, how long it has been senescent and the surrounding biological environment.
This variability is important because it helps explain why cellular senescence can have beneficial effects in some circumstances and harmful effects in others.
How can SASP affect neighboring cells?
SASP molecules can act through paracrine signaling, meaning signals released by one cell influence other cells nearby.
Research has shown that in some experimental settings, SASP signals can alter nearby cells, change inflammatory responses, remodel the extracellular environment and even encourage other cells to enter a senescent state. Researchers sometimes call this paracrine or secondary senescence.
This creates an important possibility: a relatively small population of persistent senescent cells may influence a larger area of tissue through the signals they release.
Is SASP always harmful?
No. SASP is another example of why the zombie-cell story is more complicated than simply labeling senescent cells as bad.
In short-lived, controlled settings, signals from senescent cells can participate in useful biological processes, including wound repair, tissue remodeling and recruitment of immune cells that help clear damaged cells.
When can SASP become a problem?
The situation may change when senescent cells persist rather than being cleared. Continued signaling from these cells can contribute to a tissue environment associated with chronic inflammation and altered function.
This does not mean that SASP is the sole cause of age-related inflammation or disease. Aging involves many interacting biological processes. Instead, researchers are investigating persistent senescent-cell signaling as one potential contributor.
This also helps explain why the accumulation of senescent cells with age has attracted so much scientific interest.
Can senescence spread from one cell to another?
Laboratory research suggests that it can under certain conditions. Signals released by senescent cells can sometimes induce features of senescence in neighboring cells, a phenomenon often described as secondary or paracrine senescence.
Recent research using human brain-cell models has provided further evidence that senescent cells can influence neighboring cell types through SASP-dependent signaling. Findings like these help researchers investigate how localized cellular senescence might affect a wider tissue environment.
However, laboratory models should not be interpreted as proof that senescence spreads throughout the human body in the same way. Translating these mechanisms into living humans remains an active area of research.
Why does SASP matter to senolytic research?
SASP helps explain why researchers are interested in strategies that do more than simply identify senescent cells.
Senolytics are being investigated for their ability to selectively eliminate certain senescent cells. Another approach involves compounds sometimes called senomorphics or senostatics, which are studied for their potential to modify harmful features of senescent cells, including aspects of SASP, without necessarily killing the cells.
These are different strategies, and neither should be interpreted as an established general anti-aging treatment for humans.
What kinds of molecules are found in the SASP?
The senescence-associated secretory phenotype is not one single molecule. It is a collection of substances that senescent cells can release into their surroundings.
Depending on the cell and the cause of senescence, the SASP can include inflammatory cytokines, chemokines, growth factors, proteases and other signaling molecules.
These signals can influence immune cells, neighboring cells and the extracellular matrix that helps support tissue structure.
This is one reason senescent cells can affect tissue biology even though they have stopped dividing.
Why does the SASP vary between senescent cells?
There is no universal SASP shared by every senescent cell.
The molecules released depend on factors such as the original cell type, the tissue, the stress that triggered senescence and how long the cell has remained senescent.
A senescent immune cell may therefore produce a different signaling profile from a senescent skin, fat or lung cell.
This variability is part of the broader concept of senotypes: distinct biological forms of cellular senescence with different molecular characteristics.
See how scientists are mapping different senescent-cell states across human tissues →
How can the SASP influence nearby healthy cells?
SASP molecules can act as signals to surrounding cells.
In some situations, those signals recruit immune cells that help remove damaged cells or support tissue repair.
In other circumstances, persistent SASP signaling can alter the behavior of nearby cells, promote inflammation or disrupt normal tissue organization.
The biological effect therefore depends heavily on context, duration and the particular mixture of SASP factors being released.
What is paracrine senescence?
Researchers use the term paracrine senescence to describe situations in which signals from a senescent cell contribute to nearby cells developing senescence-like characteristics.
This does not mean senescence behaves like an infection. Instead, signaling molecules can change stress responses and gene activity in neighboring cells.
Under some experimental conditions, this can extend the biological influence of a relatively small population of senescent cells beyond the cells themselves.
Paracrine effects are one reason researchers are interested in both the number of senescent cells and the substances those cells release.
How does the immune system interact with the SASP?
The SASP can help attract immune cells to damaged or senescent tissue.
That can be beneficial when immune cells recognize and remove senescent cells after an injury or temporary biological stress.
With aging, however, immune surveillance may become less efficient, and some senescent cells may persist despite continuing to release inflammatory signals.
This interaction between senescent cells and the immune system is an active area of aging research.
Why can persistent SASP signaling become harmful?
Short-lived SASP signaling can support useful processes such as tissue repair and immune recruitment.
The concern arises when senescent cells persist and continue releasing inflammatory and tissue-remodeling signals over long periods.
Chronic SASP activity may contribute to low-grade inflammation, changes in the extracellular matrix and altered behavior in surrounding cells.
This does not mean the SASP causes every age-related disease, but it is one mechanism researchers are investigating across multiple tissues.
How does the SASP affect tissue structure?
Some SASP factors include proteases and other molecules that can modify the extracellular matrix.
The extracellular matrix provides structural support and helps regulate how cells communicate with their surroundings.
When remodeling becomes excessive or persistent, tissue organization can change in ways that may affect function.
The specific consequences depend on the tissue and the particular senescent-cell population involved.
Can the SASP be changed without killing senescent cells?
Yes. Researchers are studying interventions designed to alter harmful features of senescent cells without necessarily eliminating the cells themselves.
These approaches are often called senomorphics or senostatics.
Instead of selectively killing senescent cells, a senomorphic strategy may try to reduce inflammatory SASP signaling or modify other aspects of the senescent phenotype.
This is conceptually different from a senolytic, although some experimental compounds may affect more than one pathway.
Learn the difference between senolytic and senomorphic strategies →
Why is SASP biology more complicated than “inflammation”?
The SASP is frequently described as inflammatory, but that description is incomplete.
Its components can include molecules involved in immune signaling, growth, tissue remodeling, cell migration and communication between cells.
Some SASP components may be harmful in one setting and useful in another.
Researchers therefore increasingly analyze specific SASP profiles rather than treating all SASP activity as a single inflammatory signal.
Can scientists measure the SASP in people?
Researchers can measure individual SASP-associated proteins and broader protein signatures in blood or tissue samples.
However, there is no single SASP blood test that can determine how many senescent cells a person has or identify every tissue contributing to the measured signals.
Many SASP-associated molecules are also produced during other biological processes, including infection, injury and ordinary immune responses.
For this reason, scientists usually combine multiple markers with information about cell state, tissue location and other features of senescence.
See how researchers identify and measure cellular senescence →
Why does the SASP matter for future senescence therapies?
Understanding the SASP may help researchers determine which senescent-cell populations are harmful and which biological signals should be targeted.
It may also help explain why an intervention that works in one tissue or disease setting does not necessarily work in another.
Future approaches may involve eliminating selected senescent cells, modifying particular SASP pathways, improving immune clearance or combining several strategies.
The goal is likely to be greater biological precision rather than simply removing every cell displaying signs of senescence.
What is the most accurate way to think about the SASP?
The SASP is best understood as a context-dependent communication system used by many senescent cells.
It can contribute to useful short-term responses, but persistent signaling from long-lived senescent cells may influence inflammation, neighboring cells and tissue structure.
That combination of beneficial and potentially harmful effects is why the SASP has become one of the central topics in modern cellular-senescence research.
Read how Zombie Cell Science evaluates emerging senescence research →
The takeaway
SASP is one of the most important concepts for understanding why persistent zombie cells may matter. Senescent cells can remain active and communicate with surrounding tissue through a complex mixture of signaling molecules.
Sometimes those signals serve useful biological functions. In other circumstances, particularly when senescent cells persist, SASP may contribute to inflammation, tissue changes and secondary senescence.
The key point is that zombie cells are not simply inactive cells waiting to be removed. Their ability to influence neighboring cells is a major reason cellular senescence has become such an important field of aging research.
Read the source material
- Review: The senescence-associated secretory phenotype in health and disease
- Birch & Gil (2020): Senescence and the SASP — therapeutic implications
- Zhang et al. (2023): Senolytics, senomorphics and SASP-targeting strategies
- Saliev & Singh (2025): Senolytics and senomorphics in cellular-senescence research
- Suryadevara et al. (2026): Human senescence mapping and senotype heterogeneity
- NIH Cellular Senescence Network (SenNet)
Educational information only; not medical advice.
Explore more source-backed guides in the Research Library →
